Federal Circuit Affirms Ultracet Decision
The U.S. Court of Appeals for the Federal Circuit upheld a lower court ruling Friday that allowed a subsidiary of India's Sun Pharmaceuticals to market a generic version of Johnson &...To view the full article, register now.
Already a subscriber? Click here to view full article